FIGURE

Figure 3

ID

ZDB-FIG-210916-3

Publication

Chen et al., 2021 - Apatinib inhibits the proliferation of gastric cancer cells via the AKT/GSK signaling pathway in vivo

Other Figures

All Figure Page

Back to All Figure Page

Figure 3

Inhibitory effect of gastric cancer cell line in the zebrafish xenograft model under apatinib treatment. (A) The survival rates and teratogenic rates of zebrafish were detected under different concentrations of apatinib. (B) Fluorescence image of subintestinal vessels in zebrafish induced by MGC-803 with/without apatinib treatment at 1 dpt. (C) Quantitative analysis of the length of newly formed vessels in zebrafish induced by MGC-803 with/without apatinib treatment. Scale bar: 50 μm. (D) Quantitative analysis of the MGC-803 cells proliferation with/without apatinib treatment at 2 dpt. Dpt: days post treatment. (E) Western blot analysis of AKT, phosphorylated AKT (p-AKT), GSK3α, phosphorylated GSK3α (p-GSK3α), GSK3β and phosphorylated GSK3β (p-GSK3β) in injected cells.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Aging (Albany NY)